.Novo Nordisk is continuing its push into genetic medicines, accepting to pay NanoVation Therapeutic...
.Innovent Biologics has created the case that its gate inhibitor-cytokine combination healthy protei...
.A stage 3 trial of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) ...
.Five months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has ...
.Ascendis Pharma has actually emerged as a prospective danger to BioMarin's Voxzogo, reporting phase...
.Though Alkeus Pharmaceuticals' oral eye disease asset fell short to substantially reduce geographic...
.With a trio of biotechs striking the Nasdaq on Friday, it was actually quick and easy to overlook a...
.Invulnerable gate inhibitors are the superheroes of cancer cells therapy. Medicines like Bristol My...
.Accept to recently's Chutes & Ladders, our roundup of significant management hirings, firings as...
.Regeneron is back with long-term follow-up for its own LAG-3 inhibitor and also PD-1 prevention com...